Posted on 9/1/17
What About A Bristol-Myers Squibb Takeover By Pfizer?
Pfizer (PFE) has a history of making big acquisitions, and has access to very cheap cash right now -- this would allow the company to make . . .
Posted on 9/1/17
Why Teva Pharmaceutical Industries, Shoe Carnival, and Hasbro Jumped Today
The major benchmarks all moved higher Thursday, with the Nasdaq Composite producing the biggest gains. The growing devastation left in the wake of Hurricane Harvey still . . .
Posted on 9/1/17
Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences
On Monday, Gilead Sciences' (NASDAQ:GILD) wowed investors with an $11.9 billion deal to buy clinical-stage CAR-T drugmaker Kite Pharma (NASDAQ:KITE), and on Wednesday, the FDA approved . . .
Posted on 8/31/17
Celgene Has Led Bluebird Into A Crowded Field
Two years ago, when Lenti-D and LentiGlobin were still its lead product candidates, I viewed bluebird bio (BLUE) as industry leader in the development of gene . . .
Posted on 8/31/17
Teva: A Complete Overview
Teva down 60% YTD, what happened?In Teva's (NYSE:TEVA) latest earnings report, the company reported a goodwill impairment charge of $6.1B, as widely reported by financial news . . .
Posted on 8/31/17
Merck's Growth Catalyst
Photo creditMerck (MRK) shares have been stuck in neutral for some time as the company’s growth rates haven’t been enough to spur buyer interest. Of course, . . .
Posted on 8/31/17
Merck: Keytruda As A Growth Driver
Merck (MRK) has been struggling to drive top-line growth for years, resulting in a lack of growth of its share price as well. But now, its . . .
Posted on 8/31/17
Celgene Continues Support In Latest Financing Round For ARMO BioSciences
Quick TakeBiopharmaceutical company Celgene (CELG) has participated in the $67 million Series C-1 financing round of ARMO BioSciences.ARMO is a clinical stage company developing a pipeline . . .
Posted on 8/30/17
PrescribeWellness Partners With AmerisourceBergen
IRVINE, Calif.--(BUSINESS WIRE)--PrescribeWellness, the cloud-based software services company whose mission is to inspire collaboration for better health through technology, and AmerisourceBergen, one of the largest global . . .
Posted on 8/28/17
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Boston Pharmaceuticals, Inc. (hereafter, Boston Pharmaceuticals) today announced they have entered into a worldwide licensing agreement for Daiichi . . .
Posted on 8/28/17
J&J Investors Should Ignore The Noise Of Cancer Lawsuits For Now
Recently aCalifornia jury ordered Johnson & Johnson (NYSE:JNJ) to pay $471 million to a woman who claimed that using the company’s talc-based products since age 11 . . .
Posted on 8/28/17
Aramark Named One Of The Best Places To Work For Disability Inclusion
Aramark (NYSE: ARMK), a global leader in food, facilities management and uniforms, was named one of the Best Places to Work for Disability Inclusion by the . . .
Posted on 8/28/17
Merck: Shareholders Will Fail To Be Rewarded Here
Investment ThesisMerck (MRK) has truly great prospect with its Keytruda program, but its shares are just too expensive at the moment.Business Prospects: KeytrudaMerck's Keytruda is a . . .
Posted on 8/28/17
Hershey Evolves Creative Agency Roster
HERSHEY, Pa., Aug. 25, 2017 (GLOBE NEWSWIRE) -- The Hershey Company (HSY) announces an evolution to its U.S. creative agency roster. As of January 2018, Hershey . . .
Posted on 8/26/17
Zelis Healthcare Recognized for Seventh Year on Prestigious Inc. 5000
BEDMINSTER, N.J.--(BUSINESS WIRE)--For the seventh time, Zelis Healthcare has earned recognition on Inc. Magazine’s Inc. 5000, the most prestigious ranking of the nation's fastest-growing private companies. . . .
Posted on 8/25/17
Krystal Biotech Wants To Raise $35 Million In IPO
Gene therapy company Krystal Biotech (KRYS) intends to raise up to $35 million in gross proceeds from an IPO of its common stock.Krystal Biotech is a . . .
Posted on 8/25/17
California Jury Drops A $417 Million Talc Bomb On J&J
A California jury dropped a bombshell on Johnson & Johnson (JNJ) earlier this week when it awarded $417 million to a 63-year old woman who claimed . . .
Posted on 8/25/17
Can Merck Maintain Its Dividend Payment Despite Revenue Woes?
Merck & Co. Inc. (NYSE:MRK) has over a 20-year long track record of consistent dividend payments with impressive growth rate to boot. While the stock price . . .
Posted on 8/25/17
Boy, Were We Wrong About Rite Aid and Opko Health
Everyone makes mistakes, and this week's Industry Focus theme week is all about celebrating (and cringing) at some of the biggest mistakes we've made on the . . .
Posted on 8/25/17
GPB Capital Acquires Four Physical Therapy Center Operators
GPB Capital has established a presence in the healthcare industry through acquisitions of four physical therapy center
Posted on 8/24/17
Johnson & Johnson Is Doing Just Fine
A growing number of investors seem to believe that Johnson & Johnson (JNJ) is overvalued after seeing some relatively weak financial results. The combination of a . . .
Posted on 8/24/17
How Johnson & Johnson Makes Most of Its Money
As you might expect, Johnson & Johnson (NYSE:JNJ) makes a lot of money. Last year, the healthcare giant generated revenue totaling nearly $72 billion. Over the . . .
Posted on 8/23/17
Johnson & Johnson: A Dividend Aristocrat You Must Neither Sell Nor Buy At These Prices
We are beginning a series of 10 articles on 10 blue chip dividend aristocrats, some, if not all, of which are must-haves in any proper biotech . . .
Posted on 8/23/17
Teva: The Perfect Storm Has Created The Perfect Opportunity
Investment ThesisTeva (TEVA) is a highly-leveraged company which faced a large one-off goodwill impairment which caused its share price to fall to decade lows. I humbly . . .
Posted on 8/23/17
Pfizer: Pharma Dividend Superstar
Pfizer Inc. (NYSE:PFE) stock comes with a rather formidable dividend yield of 3.92 percent, which, coupled with a strong growth rate, makes it one of the . . .

